"The recent deaths of more than 20 children in the central state of Madhya Pradesh have left Indians shaken and angry, as the country that sees itself as a pharma powerhouse faces painful issues regarding its drug safety protocols. All of the victims were aged under five. Most of them died over the past month after they were prescribed contaminated cough syrup, containing fatal levels of diethylene glycol (DEG) an industrial solvent and antifreeze chemical that can trigger acute kidney failure."
"It was the same deadly compound linked to past tragedies connected to Indian-made cough syrup, including the deaths of 18 children in Uzbekistan in 2023, as well as around 70 children in The Gambia in 2022, and well 12 in Jammu in 2019 and 2020. Owner of 'Sresan Pharmaceuticals' arrested India's Central Drugs Standard Control Organization (CDSCO), state officials and other regulatory bodies responded to the latest tragedy by banning the syrup's sale across multiple states, issuing pediatric cough syrup advisories,"
More than 20 children under five died in Madhya Pradesh after being prescribed contaminated cough syrup containing fatal levels of diethylene glycol (DEG), an industrial solvent and antifreeze that can cause acute kidney failure. The same compound has caused previous mass poisonings linked to Indian-made cough syrup in Uzbekistan (18 deaths in 2023), The Gambia (around 70 deaths in 2022), and Jammu (12 deaths in 2019-2020). Regulators banned the syrup's sale across multiple states, issued pediatric advisories, initiated inspections at 19 manufacturing units in six states, shut down the manufacturer Sresan Pharmaceuticals, and arrested its owner. Experts warn of uneven state regulation, corrupt testing, and poor inter-state coordination.
Read at www.dw.com
Unable to calculate read time
Collection
[
|
...
]